Please login to the form below

Not currently logged in

Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more

The latest movers in healthcare comms

Oxford PharmaGenesis appoints new medical writer

Corin Wing

Independent HealthScience communications consultancy Oxford PharmaGenesis has appointed Corin Wing as a Principal Medical Writer.

Wing, who has a background in medical research, has worked across a broad range of therapy areas, strategic initiatives and deliverables.

She said: "I am thrilled to be joining such a dynamic and pioneering organization, who truly value their staff and set out to make a real difference for patients. Importantly, they also strive to enhance the discipline of medical communications by freely offering their extensive knowledge, leadership and support at events such as the European ISMPP meeting that takes place later this month. I am very excited to be part of this.”

Wing brings experience in medical writing from Ogilvy 4D, 7.4 Limited, Abacus International and most recently Envision Pharma, where she served as Principal Medical Writer from 2016.

Oxford PharmaGenesis CEO, Chris Winchester, said: “I am delighted to welcome Corin. Our motto is ‘Powerful thinking, dedicated to your success’, so it’s great that another talented writer has joined our expanding team delivering superlative service to all our clients.”

Vicky Bramham joins Reynolds-Mackenzie

Vicky Bramham

Open Health has appointed Vicky Bramham as Managing Director of its PR company Reynolds-MacKenzie, to drive further growth of the London-based healthcare agency.

Bramham will report into Matt de Gruchy, who joined Reynolds-Mackenzie as chief executive officer at the beginning of 2018.

Commenting on her appointment, de Gruchy said, “We are genuinely delighted to be welcoming someone to our team with the experience and track-record in healthcare PR of Vicky. 2019 represents an exciting year for Reynolds-MacKenzie and Open Health, fuelled by the recent merger with Peloton Advantage in the US.  I know Vicky will be a fantastic leader and driver of the next phase of our growth”.

With over 18 years’ healthcare communications experience, Bramham joins Reynolds-MacKenzie from Edelman, where she was a senior director overseeing the UK health business.

Prior to this, she has held senior roles for other agencies including Virgo, Weber Shandwick and Inventiv Health.

Bramham said: “I am truly delighted to be taking on this role, leading the talented Reynolds-MacKenzie team at this exciting time in the agency’s evolution.  I look forward to continuing to maintain the agency’s excellent reputation in UK media relations, but also bringing my experience to bear in growing our client base internationally and in closer partnership with other OPEN Health practices.”

Porterhouse Medical strengthens team with promotion

Amanda Hyne

Porterhouse Medical has promoted Amanda Hyne to senior medical writer within its scientific services team.

Over the past year Hyne has contributed to conferences and meetings including the World Federation of Hemophilia (WFH) congress and the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (ISTH SSC) meeting.

Porterhouse said: Amanda has displayed outstanding flexibility, diligence and an amazing can-do attitude in her work, combined with super writing skills and great confidence in building and maintaining relationships with clients and healthcare professionals.”

W Communication Agency announces new CEO


Swedish-based creative communications agency W Communication has appointed Sunil Ramkali as its new CEO.

He takes the reins from Lisa Önnerlid, who has been serving as CEO for the past 16 years. She continues to stay with the company, taking on a board role.

Meanwhile Ramkali has been responsible for the agency’s life science client since 2011. He has 30 years’ experience in sales and marketing within the pharmaceutical industry having previously held roles for AstraZeneca and ALK.

He said: “Our niche in international B2B communications with a specific focus in life science, industry and technology has made us one of the region’s most successful agencies. A legacy we will continue to build in my new role at W.”

Ramkali will run the agency together with Elisabet Ek, who is responsible for the agency's industrial customers and partner at the agency.

Önnerlid said: “Building and running an agency is a great experience and I’m proud of what we have achieved over the past 20 years at W. Sunil and Elisabet are two of the smartest and best people I know, and it will be exciting to see how they develop the agency going forward.”

10th January 2019

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Research Partnership

Research Partnership has joined Ashfield Advisory, the consulting division of healthcare marketing services company, Ashfield. As the market insights specialist...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...